Risk of glomerular diseases, proteinuria and hematuria following mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines.

Franco Wing Tak Cheng Carlos King-Ho WongSimon Xiwen QinCeline Sze Ling ChuiFrancisco Tsz Tsun LaiXue LiEric Yuk Fai WanEsther W ChanChi Ho AuXuxiao YeSydney Chi-Wai Tang Ian Chi Kei Ck Wong

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)

There was no evidence of increased risks of de novo or relapsing GD with either BNT162b2 or CoronaVac vaccines.

Keyphrases

sars cov
multiple sclerosis
respiratory syndrome coronavirus
disease activity
binding protein
diabetic nephropathy
rheumatoid arthritis
endothelial cells
climate change